Introduction {#sec1-1}
============

Kidney is susceptible to ischemia--reperfusion injury (IRI) during a number of events including hypotension, sepsis, surgical protocols such as partial nephrectomy and cardiac bypass surgery, as well as during kidney transplantation.\[[@ref1][@ref2]\] IRI is a capital cause of kidney dysfunction often following acute kidney failure, leading to high mortality among patients in intensive care who require dialysis.\[[@ref3]\] Besides, renal IRI can contribute to delayed restoration of renal function and acute rejection after transplantation.\[[@ref4]\]

Clinical outcomes of IRI or ischemic acute kidney injury (AKI) depend on the intensity of the injury and range from slight alternations in renal function to an assignment for dialysis or transplantation. Blood flow in the process of reperfusion phase can yield oxygen free radicals, which cause lipid peroxidation as a cardinal pathway of free radical tissue injuries.\[[@ref5]\] Thus, generation of free radicals accelerates renal tissue injury through peroxidation of membrane lipids and oxidative damage of proteins and DNA participation in apoptosis and cell death.\[[@ref6]\] Furthermore, downregulation of the antioxidant enzyme system such as glutathione peroxidase (GPX), catalase (CAT), and superoxide dismutase (SOD) could be liable for the pathophysiology of renal injury and IRI.\[[@ref7]\] The potential pathological mechanisms of IRI include inflammation, oxidative stress, and apoptosis, which eventually lead to cell death. For this reason, multifunctional molecules with antioxidative, anti-inflammatory, and antiapoptotic properties are ideal protective agents against the outcomes of IR.\[[@ref8]\] Furthermore, antioxidant therapy can protect against oxidative damage prompted by IR.\[[@ref9]\] The guarding property of antioxidants may be linked to the capacity of antioxidant compounds to normalize primitive intracellular events connected to the movement of oxidative damage.\[[@ref10]\]

Thioctic acid (TA), an endogenous short chain fatty acid, is a cofactor for multiple mitochondrial dehydrogenase enzymes. TA is suggested as a perfect antioxidant in fat, water-soluble, a reactive oxygen species (ROS) scavenger, a chelate of metal, and regenerates endogenous natural antioxidants and gene expression.\[[@ref11]\] This study aimed to examine the effect of TA preconditioning on kidney function as well as oxidative stress and inflammatory markers in serum and kidney homogenates in IR rat.

Materials and Methods {#sec1-2}
=====================

Materials {#sec2-1}
---------

All materials were in analytical grade and purchased from Sigma or Merck Chemical Companies.

Experimental group {#sec2-2}
------------------

Thirty male Sprague-Dawley rats (8 weeks) weighing 200 ± 15 g were kept under constant laboratory conditions (24 ± 1°C, 50 ± 10 humidity) and a 12-h light--dark cycle with *ad libitum* access to standard rodent chow and water in the animal laboratory of Razi Herbal Medicines Research Center. Furthermore, the rats were randomly divided into three equal groups (10 rats in each group) that were named as follows: (1) sham-operated group (sham group), wherein rats were treated only with separating the bilateral renal arteries and veins; (2) renal IR group (I/R group), wherein the rats were treated with ischemia by clamping the bilateral renal arteries and veins for 45 min and subsequent 24-h reperfusion;\[[@ref12]\] and (3) renal I/R + TA group (TA group), wherein the rats were pretreated with TA. TA, 50 mg/kg, was administered to rats by daily intraperitoneal (i.p.) injection for 2 weeks before induction of renal IR; 24 hours after reperfusion rats were anesthetized with an i.p. injection of ketamine--xylosine (90 + 10 mg/kg body mass), a blood sample was collected from their heart and transferred into test tubes. Serum samples were prepared by 15 min of centrifugation of blood at 5000 *×g* and were stored at −70°C for measurements. The right kidney was rapidly removed and homogenized for biochemical analysis. All experimental procedures were approved by the Ethics Committee for Animal Care and Use at the Lorestan Medical Sciences University (No. LUMS2015-1902).

Biochemical analysis {#sec2-3}
--------------------

Serum creatinine (Cr) and urea were determined as a marker of kidney function by kits (Pars Azmoon, Iran) according to its manufacturers. The level of malondialdehyde (MDA) was measured using thiobarbituric acid by the spectrophotometric method at 532 nm. Glutathione (GSH) was assayed in serum and renal homogenates based on the development of a relatively stable yellow color when 5,5′-dithiobis-2′-nitrobenzoic acid was added to sulfhydryl compounds. Furthermore, the reaction color was read at 412 nm. Nitric oxide (NO) metabolites (nitrate and nitrite, NOx) were measured with a commercial assay kit (Cayman Chemical Co., Ann Arbor, MI, USA) based on Griess reaction. Activities of superoxide dismutase (SOD). CAT, GPX, and myeloperoxidase (MPO) were assayed by continuous spectrophotometric rate determination. The results of activists of SOD, CAT, GPX, and MPO were expressed as unit/mg of protein. The levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were determined by an ELISA kit (Immunotech, France) in serum and kidney homogenates.

Statistical analysis {#sec2-4}
--------------------

All data were expressed as mean ± standard deviation. Multiple analysis of variance (Tukey\'s) test was used to compare different variables used in all groups and Pearson\'s rank correlation coefficient was used to compare the relationship between MDA and other parameters using SPSS version 16. Statistical significance was defined as *P* \< 0.05.

Results {#sec1-3}
=======

Kidney function is disturbed following IRI as represented by a notable increase in serum urea and Cr of IR group when compared with sham group \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. The levels of the cited parameters of IR rats treated with TA significantly were lower than untreated IR rats (*P* \< 0.05).

![Levels of creatinine and urea in the serum of all groups (a and b, respectively). ^a^Indicates significance of data comparing the sham group with other groups (*P* \< 0.001). ^b^Indicates significance of data comparing IR group with other groups (*P* \< 0.001)](IJPVM-10-176-g001){#F1}

IRI induced oxidative stress and inflammation in both serum and kidney homogenates. TA exhibited an attenuating effect on oxidative stress. Thus, the level of GSH and activates of SOD, CAT, and GPX was higher in the treated group than the untreated group \[[Table 1](#T1){ref-type="table"}\]. Over and above, the levels of MDA and NO were lower in the treated group. Inflammatory markers, TNF-α, IL-6, and MPO significantly increased in IR group rather than the sham group \[[Table 2](#T2){ref-type="table"}\]. Inflammatory markers were lower in the treated group when compared with untreated group (*P* \< 0.001). There was no difference in the activity of MPO in both serum and kidney homogenates between sham and IR-treated groups.

###### 

Effect of thioctic acid on oxidative stress markers, MDA, GSH, and NO levels in addition to antioxidant enzyme activities (SOD, CAT, and GSH peroxidase), in serum and renal homogenates of all groups

  Parameter                   Sham           IR                 IR + TA
  --------------------------- -------------- ------------------ ------------------
  MDA                                                           
   Serum (nmol/L)             5.10±0.23      170.29±9.71^a,b^   99.36±5.48^a,b^
   Kidney (nmol/mg protein)   3.32±0.12      35.76±2.26^a^      16.78±1.19^a,b^
  NO                                                            
   Serum (µmol/L)             25.78±1.13     55.67±2.75^a^      40.32±2.21^a,b^
   Kidney (µmol/mg protein)   0.51±0.04      0.83±0.08^a^       0.66±0.06^a,b^
  GSH                                                           
   Serum (µmol/L)             178.43±7.21    90.05±4.15^a^      136.89±6.19^a,b^
   Kidney (nmol/mg protein)   43.88±3.21     25.34±1.15^a^      35.89±2.87^a,b^
  SOD                                                           
   Serum (U/mg protein)       145.35±8.01    80.74±4.22^a^      110.87±6.12^a,b^
   Kidney (U/mg protein)      250.01±12.32   137.65±6.65^a^     201.32±9.94^a,b^
  CAT                                                           
   Serum (U/mg protein)       90.43±4.02     54.87±2.06^a^      76.12±3.11^a,b^
   Kidney (U/mg protein)      105.33±5.24    60.65±2.82^a^      83.03±3.91^a,b^
  GPX                                                           
   Serum (U/mg protein)       70.35±2.41     36.74±1.22^a^      58.67±2.54^a,b^
   Kidney (U/mg protein)      75.12±3.57     33.67±1.91^a^      60.43±2.21^a,b^

MDA=Malondialdehyde, GSH=Glutathione, NO=Nitric oxide, SOD=Superoxide dismutase, CAT=Catalase, GPX=Glutathione peroxidase, TA=Tioctic acid, IR=Ischemia--reperfusion. ^a^Indicates significance of data comparing the sham group with other groups (*P*\<0.001), ^b^indicates significance of data comparing IR group with other groups (*P*\<0.001)

###### 

Effect of thioctic acid on inflammatory markers in serum and renal homogenates of all groups

  Parameter                Sham          IR                  IR + TA
  ------------------------ ------------- ------------------- --------------------
  IL-6                                                       
   Serum (ng/L)            110.54±6.90   533.67±33.75^a^     221.32±12.21^a,b^
   Kidney (pg/mg)          125.78±8.50   2055.67±177.75^a^   1100.32±88.21^a,b^
  TNF-α                                                      
   Serum (ng/L)            100.43±5.36   244.56±13.46^a^     125.76±8.43^a,b^
   Kidney (pg/mg)          9.87±0.65     67.51±3.43^a^       39.32±1.89^a,b^
  MPO                                                        
   Serum (U/mg protein)    1.35±0.06     4.74±0.26^a^        1.45±0.07^b^
   Kidney (U/mg protein)   0.55±0.11     3.01±0.62^a^        0.61±0.13^b^

IL-6=Interleukin-6, TNF-α=Tumor necrosis factor-α, MPO=Myeloperoxidase, TA=Tioctic acid, IR=Ischemia--reperfusion. ^a^Indicates significance of data comparing the sham group with other groups (*P*\<0.001), ^b^indicates significance of data comparing IR group with other groups (*P*\<0.001)

The correlation between MDA and other measurable parameters is presented in [Figure 2](#F2){ref-type="fig"}. TNF-α, IL-6, MPO, and NO had a high positive correlation with MDA but vice versa about other cited parameters.

![Correlation between malondialdehyde with inflammatory and oxidative stress markers](IJPVM-10-176-g002){#F2}

Discussion {#sec1-4}
==========

We investigated the effect of two weeks' pretreatment of i.p. injection of TA, 50 mg/kg, on kidney function tests, oxidative stress, and inflammatory markers in serum and kidney homogenates of the IR rat model. TA protected against kidney dysfunction due to an elevation of antioxidant property and reducing inflammatory responses in IR rat. Higher levels of urea and Cr in the serum of IR rats than the sham group following induction of IR propose substantial deterioration of kidney function \[Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}\]. TA showed an improving effect on kidney function in IR rats due to lower levels of renal function parameters in the treated group than untreated (*P* \< 0.001). The diminishing effect of TA on serum Cr and urea of IRI in simultaneous kidney--pancreas transplantation has been shown.\[[@ref9]\]

Presumably, oxidative stress is a main initiator and motivator of IRI.\[[@ref13]\] The raising levels of MDA and NO and diminishing of activities of antioxidant enzymes (SOD, CAT, and GPX) and level of GSH in serum and kidney homogenates indicated severe oxidative stress induction due to IR \[[Table 1](#T1){ref-type="table"}\]. Over and above, similar cited changes were observed in streptozotocin-induced diabetic rats exposed to renal IRI that confirms our results.\[[@ref7][@ref12]\] Based on our findings \[[Table 1](#T1){ref-type="table"}\], the treatment significantly compensated cited changes in the IR rat model (*P* \< 0.001). The vitamin alleviated IRI by boosting the first lines of defense against free radicals with elevation of GSH level and SOD activity. The treatment may scavenge MDA and NO within IR tissue. NO convoy tissue versus IRI in low level, consequently its vasodilatory, antioxidant, and anti-inflammatory qualities. NO has an important role in the pathophysiology of renal IRI at a higher level.\[[@ref14]\] Besides, inhibition of inducible nitric oxide synthase (iNOS) expression, iNOS activity, and scavenging of NO can attenuate or prevent NO-mediated renal injury.\[[@ref15]\] A similar effect of the treatment on the levels of MDA and MPO as well as activities of GSH, SOD, and GPX, respectively, in renal sciatic homogenate on rats' renal and sciatic nerve IR damage has been shown.\[[@ref16][@ref17]\] The activities of indigenous antioxidant enzymes, composed of SOD, CAT, and GPX, along with the level of GSH as ROS scavenger are the main contributors of reducing the tissue injury caused by IR.\[[@ref18]\] Therefore, TA is a strong inhibitor of oxidative stress in IRI.

Inflammatory events raise in IR owing to expanding neutrophil infiltration and oxidative stress.\[[@ref7]\] Inflammation is a principal player in renal IRI, so a constraint of inflammatory reactions is a strategy for convoy renal tissue. Cytokines such as IL6 and TNF-α play a major role in renal dysfunction of IRI.\[[@ref19]\] MPO is the most abundant proinflammatory enzyme stored in the azurophilic granules of neutrophilic granulocytes.\[[@ref20]\] Furthermore, MPO has a role in the pathogenesis of renal IRI, and it is generally used as a marker of local and systemic inflammatory.\[[@ref21]\] The levels of inflammatory markers, TNF-α and IL-6, in addition to the activity of MPO in serum and renal tissues of the IR group were noticeably higher than the sham group \[[Table 2](#T2){ref-type="table"}\]. The treatment showed potent anti-inflammatory effect (*P* \< 0.001). In our research, between MPO activity in serum and kidney homogenates of the treated IR rats and sham rats, there was no difference. Previously, the reducing effect of TA preconditioning on inflammatory markers such as TNF-α and IL-6 as well as early kidney dysfunction and clinical posttransplant pancreatitis was represented.\[[@ref9]\] It is suggested that any treatment that could lead to augment of activity of antioxidant enzymes and GSH level, but reduces the activity of MPO and NO level may prevent or mitigate the consequences of IR. Therefore, TA is a perfect treatment for prevention of IRI. IR induces oxidative stress and inflammation by reduction of expression of nuclear-factor-E2-related factor 2 (Nrf2) and thioredoxin reductase-2 (TrxR2) as well as an elevation of expression of nuclear-factor-kappa B (NF-kB).\[[@ref2][@ref22][@ref23]\] Furthermore, the elevation of the Nrf2/heme oxygenase-1 (HO-1) pathway played an antiapoptotic role.\[[@ref24]\] Thus, the antioxidant, anti-inflammatory, and antiapoptosis effects of the treatment probably are based on the promotion of expression of Nrf2, HO-1, and TrxR2 along with the reduction of expression of NF-kB.

In this research, the correlation between MDA as a general marker of oxidative stress with other cited parameters is reported in [Figure 2](#F2){ref-type="fig"}. Renal IRI increases with an increase in MPO, IL-6, and NO as well as a decrease in SOD, CAT, GPX, and GSH (*P* \< 0.005). Therefore, TA as a multifunctional compound with antioxidant and anti-inflammatory activities ameliorated IRI.

Conclusions {#sec1-5}
===========

TA improved kidney dysfunction in the renal IRI rat model following decrement levels of oxidative stress and inflammatory markers along with boosting endogenous antioxidant system.
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